Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
256 studies found for:    603
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions
Condition: Human Papillomavirus-Related Malignant Neoplasm
Intervention: Biological: ZFN-603 and ZFN-758
2 Completed LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: LFB-R603
3 Completed Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
Condition: Dry Eye Syndromes
Intervention: Drug: cyclosporine A
4 Completed Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
Condition: Dry Eye Syndromes
Intervention: Drug: cyclosporine
5 Completed Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
Condition: Dry Eye Syndromes
Intervention: Drug: cyclosporine
6 Active, not recruiting Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: adult human mesenchymal stem cells
7 Recruiting Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Conditions: Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
Intervention: Drug: Ublituximab
8 Completed
Has Results
Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Polysaccharide Diphtheria Conjugate Vaccine
9 Active, not recruiting Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: adult human mesenchymal stem cells;   Drug: Placebo
10 Completed A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Bortezomilb
11 Completed Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan
Conditions: Acute Lung Injury;   Systemic Inflammatory Response Syndrome
Intervention: Drug: Sivelestat sodium hydrate
12 Completed Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Placebo;   Drug: PROCHYMAL adult human mesenchymal stem cells
13 Active, not recruiting Lu AE58054 in Patients With Mild to Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: Lu AE58054
14 Completed Washington State Community Expedited Partner Treatment (EPT) Trial
Conditions: Gonorrhea;   Neisseria Gonorrhoeae;   Chlamydia Trachomatis
Interventions: Other: Patient delivered partner therapy;   Behavioral: Targeted public health partner services
15 Active, not recruiting Von Hippel-Lindau Disease Genetic Epidemiology Study
Conditions: Von Hippel Lindau Disease;   Kidney Neoplasms
Intervention:
16 Completed
Has Results
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Besifloxacin;   Drug: Vehicle (Placebo)
17 Terminated Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure
Condition: Congestive Heart Failure
Intervention: Device: Cardiac Compass with OptiVol Fluid Status Monitoring
18 Completed Anesthetics and Auditory, Visceral, and Heat Evoked Potentials
Condition: Healthy
Interventions: Drug: Propofol;   Drug: Remifentanil;   Drug: S-Ketamine;   Drug: Sevoflurane
19 Unknown  Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Condition: Oral Mucositis
Intervention: Device: Caphosol
20 Completed Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)
Condition: Acute Spinal Cord Injury
Interventions: Drug: SUN13837 injection;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years